tert-Butyl cis-5-methylenehexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate

Catalog No. :
ACJLEG378
CAS No. :
139228-12-9
Molecular Formula :
C13H21NO2
Molecular Weight :
223.32

IUPAC Name:tert-butyl (3aR,6aS)-5-methylenehexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate

tert-Butyl cis-5-methylenehexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$73.00Login to see priceInquiryInquiry
250mg95%$141.00Login to see priceInquiryInquiry
1g95%$357.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl cis-5-methylenehexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate
IUPAC Nametert-butyl (3aR,6aS)-5-methylenehexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate
MDL No.MFCD30163177
Molecular FormulaC13H21NO2
Molecular Weight223.32
SMILESO=C(N1C[C@@]2([H])[C@@](CC(C2)=C)([H])C1)OC(C)(C)C
InChI KeyQCJGDXIONIXKEH-PHIMTYICSA-N
Synonymtert-butyl (3aR,6aS)-5-methylenehexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate;Cyclopenta[c]pyrrole-2(1H)-carboxylic acid, hexahydro-5-methylene-, 1,1-dimethylethyl ester, (3aR,6aS)-rel-;tert-butyl 5-methylenehexahydrocyclopentyl[c]pyrrole-2-(1H)-carboxylate
CAS No.139228-12-9

Synthetic Route by SureRoute

1. ACJLEG378 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYQCR067 route compound structure diagram
    ACYQCR067146231-54-1 In Stock
  2. Plus
  3. ACRWCM710 route compound structure diagram
    ACRWCM7102065-66-9 In Stock
  4. Then
  5. ACJLEG378 route product structure diagram
    ACJLEG378139228-12-9
Inquiry

2. ACJLEG378 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJLEG378 route product structure diagram
    ACJLEG378139228-12-9
Inquiry

Comments (0)